文献速递肝胆胰外科围术期管理与 ERAS

围术期新鲜红细胞输注可能对肝移植受者生存产生负面影响

Perioperative Fresh Red Blood Cell Transfusion May Negatively Affect Recipient Survival After Liver Transplantation.
PubMed 文献 · Ann Surg · 2018-01-01

该研究评估围术期新鲜红细胞输注与肝移植受者生存的关联。在343例围术期输血受者中,基于输血量等倾向性评分1:1匹配91对,中位随访60个月,新鲜红细胞组1/2/5年生存率低于非新鲜组[HR=2.37 (1.43-3.94), P=0.001],多变量分析证实新鲜红细胞输注与死亡风险增加独立相关。

要点

  • 新鲜红细胞输注与肝移植受者死亡风险增加相关(HR=2.37)。
  • 所有输注红细胞均去白细胞并辐照,提示新鲜制品中活白细胞可能有害。
  • 倾向性评分匹配后结论仍显著(HR=2.23)。

核心结论

  • 围术期新鲜红细胞输注可能对肝移植受者生存产生负面影响。

研究设计与样本

  • 回顾性队列研究,纳入343例围术期接受红细胞输注的肝移植受者。
  • 基于输血产品量等倾向性评分1:1匹配91对(非新鲜组91例 vs 新鲜组91例)。
  • 采用Cox模型进行生存分析。

主要发现

  • 匹配前新鲜红细胞组输注3 U(2-6 U)新鲜红细胞,中位随访60个月,343例中60例(17.5%)死亡。
  • 匹配前1/2/5年生存率:非新鲜组94.7%/92.0%/85.8%,新鲜组82.9%/76.0%/72.0%[HR=2.37 (1.43-3.94), P=0.001]。
  • 匹配后新鲜红细胞组输注3 U(2-5 U)新鲜红细胞,中位随访56个月,182例中35例(19.2%)死亡。
  • 匹配后1/2/5年生存率:非新鲜组95.6%/93.2%/86.0%,新鲜组85.7%/78.0%/73.0%[HR=2.23 (1.43-3.94), P=0.028]。
  • 多变量分析显示新鲜红细胞输注与死亡风险增加显著相关:匹配前HR=2.33 (1.35-4.01), P=0.002;匹配后HR=3.20 (1.51-6.78), P=0.002。

关键数值与推荐

  • 所有3230单位输注红细胞均经去白细胞和辐照处理。
  • 新鲜红细胞组输注量:匹配前3 U(2-6 U),匹配后3 U(2-5 U)。

临床怎么用

  • 肝移植围术期输血时,应关注新鲜红细胞制品中活白细胞可能带来的不利影响。
  • 在满足临床需求前提下,可优先考虑非新鲜去白细胞辐照红细胞制品。

局限性

  • 回顾性研究设计,可能存在未测量混杂因素。
  • 样本量有限,结论需前瞻性研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study is to evaluate the association between fresh red blood cell (RBC) transfusion and recipient survival after liver transplantation. BACKGROUND: Fresh RBC products contain many viable leukocytes. Allogeneic leukocytes are responsible for adverse transfusion reactions in the immunocompromised host. METHODS: Among 343 liver transplant recipients who underwent perioperative RBC transfusion, 91 of 226 who did not receive fresh RBCs were matched with 91 of 117 who received fresh RBCs with 1:1 matching ratio using the propensity score based on the amount of transfused blood products and others. Survival analysis was performed using the Cox model. RESULTS: All transfused 3230 RBCs were leukoreduced and irradiated. Before matching, recipients in fresh RBC group received 3 U (2-6 U) of fresh RBCs. After a median follow-up of 60 months, 60 of 343 recipients (17.5%) died. Survival probability at 1/2/5 years after transplantation was 94.7%/92.0%/85.8% for nonfresh RBC group and 82.9%/76.0%/72.0% for fresh RBC group [death hazard ratio (HR) = 2.37 (1.43-3.94), P = 0.001]. In multivariable analysis, fresh RBC transfusion was significantly associated with increased death risk [HR = 2.33 (1.35-4.01), P = 0.002]. After matching, recipients in fresh RBC group received 3 U (2-5 U) of fresh RBCs. After a median follow-up of 56 months, 35 of 182 recipients (19.2%) died. Survival probability at 1/2/5 years was 95.6%/93.2%/86.0% for nonfresh RBC group and 85.7%/78.0%/73.0% for fresh RBC group [HR = 2.23 (1.43-3.94), P = 0.028]. Multivariable analysis confirmed a significance of fresh RBC transfusion [HR = 3.20 (1.51-6.78), P = 0.002]. CONCLUSION: Our findings suggest a potential negative impact of fresh RBC transfusion on the survival of patients undergoing liver transplantation.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Han S, Kwon JH, Jung SH, et al. Perioperative Fresh Red Blood Cell Transfusion May Negatively Affect Recipient Survival After Liver Transplantation. Ann Surg. 2018. PMID: 27805962. doi:10.1097/SLA.0000000000002062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。